Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Humira (adalimumab) / AbbVie

NCT02557295: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Terminated

N/A

248

Celltrion

Rheumatoid Arthritis

03/20

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites